Trial for Bundibugyo Ebola treatment starts in DRC, WHO says
ONP Summary
The Bundibugyo Ebola outbreak in the Democratic Republic of Congo, officially declared in May, has killed over 400 people while spreading through the eastern provinces. A research study testing new treatments began this week, but faces obstacles from public skepticism and carries broader economic risks that could deepen poverty and increase child mortality significantly.
Progressive: Progressive outlets stress the socioeconomic catastrophe—mass impoverishment, excess child deaths, community violence—portraying the outbreak as exposing systemic health system collapse.
Moderate: Moderate outlets balance reporting on disease transmission and community distrust with perspectives from frontline health workers on trust-building and epidemic management.
Conservative: Conservative outlets highlight the clinical milestone of the new treatment trial and international WHO coordination as momentum-shifting interventions against the outbreak.
이 뉴스, 어떠셨어요?
한 번의 탭으로 반응을 남겨요 · 로그인 불필요
July 2 - A treatment trial for the Bundibugyo Ebola outbreak in the Democratic Republic of Congo enrolled its first patient on Thursday, marking a milestone in efforts to combat the epidemic, WHO chief Dr.
Tedros Adhanom Ghebreyesus told reporters. ...